Prognostic Impact of Blood Transfusion After Primary Angioplasty for Acute Myocardial Infarction. Analysis From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial

JACC: Cardiovascular Interventions

Volumn 2, Issue 7, 2009, Pages 624-632

  Nikolsky, Eugenia ^a   Mehran, Roxana ^a   Sadeghi, H Mehrdad ^b   Grines, Cindy L ^c   Cox, David A ^d   Garcia, Eulogio ^e   Tcheng, James E ^f   Griffin, John J ^g   Guagliumi, Giulio ^h   Stuckey, Thomas ⁱ   Turco, Mark ^j   Fahy, Martin ^a   Lansky, Alexandra J ^a   Stone, Gregg W ^a  

^a NewYork Presbyterian Hospital   (United States)

^b SHARP HEALTHCARE   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d Mid Carolina Cardiology   (United States)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^g Sentara Virginia Beach General Hospital   (United States)

^h OSPEDALI RIUNITI   (Italy)

ⁱ MOSES H CONE MEMORIAL HOSPITAL   (United States)

^j WASHINGTON ADVENTIST HOSPITAL   (United States)

more..

Author keywords

bleeding; myocardial infarction; primary angioplasty; transfusion

Indexed keywords

ABCIXIMAB;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ANEMIA; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; GENDER; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VASCULAR DISEASE;

AGE FACTORS; AGED; ANEMIA; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; ERYTHROCYTE TRANSFUSION; FEMALE; HEART DISEASES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 67650608008     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.05.004     Document Type: Article

References (20)

1. Wu W.C., Rathore S.S., Wang Y., et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001) 1230-1236
2. Sabatine M.S., Morrow D.A., Giugliano R.P., et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
3. Alexander K.P., Chen A.Y., Wang T.Y., et al., CRUSADE Investigators. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. Am Heart J 155 (2008) 1047-1053
4. Rao S.V., Jollis J.G., Harrington R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (2004) 1555-1562
5. Yang X., Alexander K.P., Chen A.Y., et al., CRUSADE Investigators. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46 (2005) 1490-1495
6. Shishehbor M.H., Madhwal S., Rajagopal V., et al. Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 2 (2009) 46-53
7. Kinnaird T.D., Stabile E., Mintz G.S., et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 92 (2003) 930-935
8. Stone G.W., Grines C.L., Cox D.A., et al., Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346 (2002) 957-966
9. Nutritional anemias. Report of a WHO scientific group (1968), World Health Organization, Geneva
10. National Kidney Foundation. K/DOQI: Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 Suppl 1 (2002) S1-S237
11. Rao S.V., Chiswell K., Sun J.L., et al. International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol 101 (2008) 25-29
12. American College of Physicians. Practice strategies for elective red blood cell transfusion. Ann Intern Med 116 (1992) 403-406
13. Hebert P.C., Wells G., Tweeddale M., et al., Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Does transfusion practice affect mortality in critically ill patients?. Am J Respir Crit Care Med 155 (1997) 1618-1623
14. Hebert P.C., Wells G., Blajchman M.A., et al., Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340 (1999) 409-417
15. Nikolsky E., Aymong E.A., Halkin A., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the CADILLAC trial. J Am Coll Cardiol 44 (2004) 547-553
16. Twomley K.M., Rao S.V., and Becker R.C. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis 21 (2006) 167-174
17. Kahn R.C., Zaroulis C., Goetz W., and Howland W.S. Hemodynamic oxygen transport and 2,3-diphosphoglycerate changes after transfusion of patients in acute respiratory failure. Intensive Care Med 12 (1986) 22-25
18. Pawloski J.R., and Stamler J.S. Nitric oxide in RBCs. Transfusion 12 (2002) 1603-1609
19. Reynolds J.D., Ahearn G.S., Angelo M., Zhang J., Cobb F., and Stamler J.S. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A 104 (2007) 17058-17062
20. Tsai A.G., Cabrales P., and Intaglietta M. Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions. Transfusion 44 (2004) 1626-1634